Literature DB >> 9748169

Cyclo-oxygenase 2 and breast cancer prevention. Non-steroidal anti-inflammatory agents are worth testing in breast cancer.

H Vainio, G Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9748169      PMCID： PMC1113937          DOI： 10.1136/bmj.317.7162.828

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Expression of cyclooxygenase-2 in human gastric carcinoma.

Authors:  A Ristimäki; N Honkanen; H Jänkälä; P Sipponen; M Härkönen
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

2.  Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

Authors:  D C Farrow; T L Vaughan; P D Hansten; J L Stanford; H A Risch; M D Gammon; W H Chow; R Dubrow; H Ahsan; S T Mayne; J B Schoenberg; A B West; H Rotterdam; J F Fraumeni; W J Blot
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-02       Impact factor: 4.254

3.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

Review 4.  Meloxicam: selective COX-2 inhibition in clinical practice.

Authors:  D E Furst
Journal:  Semin Arthritis Rheum       Date:  1997-06       Impact factor: 5.532

5.  Cyclooxygenase-2 gene expression in human breast cancer.

Authors:  M Parrett; R Harris; F Joarder; M Ross; K Clausen; F Robertson
Journal:  Int J Oncol       Date:  1997-03       Impact factor: 5.650

6.  Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines.

Authors:  X H Liu; D P Rose
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

7.  Prospective study of regular aspirin use and the risk of breast cancer.

Authors:  K M Egan; M J Stampfer; E Giovannucci; B A Rosner; G A Colditz
Journal:  J Natl Cancer Inst       Date:  1996-07-17       Impact factor: 13.506

8.  Nonsteroidal antiinflammatory drugs and breast cancer.

Authors:  R E Harris; K K Namboodiri; W B Farrar
Journal:  Epidemiology       Date:  1996-03       Impact factor: 4.822

9.  Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators.

Authors:  M P Schrey; K V Patel
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640
  9 in total
  4 in total

Review 1.  COX-2 and cancer: a new approach to an old problem.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma.

Authors:  Ying-Hui Zhi; Ruo-Shan Liu; Mao-Min Song; Yu Tian; Jin Long; Wei Tu; Ren-Xuan Guo
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

3.  Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage.

Authors:  C R Sharpe; J P Collet; M McNutt; E Belzile; J F Boivin; J A Hanley
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

Review 4.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.